ANBL2131 - A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
Navin Pinto
Study ID
Protocol Number: 24-0917
More information available at ClinicalTrials.gov: NCT06172296
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers